REQUEST A DEMO
Total
USD $0.00
Search more companies

Knoll Pharma S. R. O. (Slovakia)

Main Activities: Other Business Support Services
Full name: Knoll Pharma S. R. O. Profile Updated: July 13, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Knoll Pharma S. R. O. is an enterprise based in Slovakia. Its main office is in Bratislava. It operates in the Other Business Support Services industry. The company was established on August 13, 2011. 2 - 3 (2025) employees currently work for Knoll Pharma S. R. O.. In its most recent financial highlights, the company reported a net sales revenue increase of 150.81% in 2024. A negative growth of 52.43% was recorded in its total assets. The net profit margin of Knoll Pharma S. R. O. increased by 121.7% in 2024.

Headquarters
Drotarska cesta, 54
Bratislava; Bratislavsky; Postal Code: 81102

Contact Details: Purchase the Knoll Pharma S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Knoll Pharma S. R. O. report to view the information.
Registered Capital:
Purchase the Knoll Pharma S. R. O. report to view the information.
Financial Auditors:
Purchase the Knoll Pharma S. R. O. report to view the information.
Incorporation Date:
August 13, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Knoll Pharma S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
150.81%
Total operating revenue
144.11%
Operating profit (EBIT)
45.15%
EBITDA
51.98%
Net Profit (Loss) for the Period
44.2%
Total Assets
-52.43%
Total Equity
-54.39%
Operating Profit Margin (ROS)
122.14%
Net Profit Margin
121.7%
Return on Equity (ROE)
-12.4%
Quick Ratio
-1.3%
Cash Ratio
2.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?